187 related articles for article (PubMed ID: 16648573)
1. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery.
Visaria RK; Griffin RJ; Williams BW; Ebbini ES; Paciotti GF; Song CW; Bischof JC
Mol Cancer Ther; 2006 Apr; 5(4):1014-20. PubMed ID: 16648573
[TBL] [Abstract][Full Text] [Related]
2. Nanotherapeutics for enhancing thermal therapy of cancer.
Visaria R; Bischof JC; Loren M; Williams B; Ebbini E; Paciotti G; Griffin R
Int J Hyperthermia; 2007 Sep; 23(6):501-11. PubMed ID: 17952764
[TBL] [Abstract][Full Text] [Related]
3. Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models.
Koonce NA; Quick CM; Hardee ME; Jamshidi-Parsian A; Dent JA; Paciotti GF; Nedosekin D; Dings RP; Griffin RJ
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):588-96. PubMed ID: 26461001
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy.
Shenoi MM; Iltis I; Choi J; Koonce NA; Metzger GJ; Griffin RJ; Bischof JC
Mol Pharm; 2013 May; 10(5):1683-94. PubMed ID: 23544801
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment of IL-1 alpha and TNF-alpha potentiates the antitumour effect of hyperthermia.
Lin JC; Park HJ; Song CW
Int J Hyperthermia; 1996; 12(3):335-44. PubMed ID: 9044903
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle enhanced thermal therapies.
Shenoi MM; Anderson J; Bischof JC
Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():1979-82. PubMed ID: 19964027
[TBL] [Abstract][Full Text] [Related]
7. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery.
Paciotti GF; Myer L; Weinreich D; Goia D; Pavel N; McLaughlin RE; Tamarkin L
Drug Deliv; 2004; 11(3):169-83. PubMed ID: 15204636
[TBL] [Abstract][Full Text] [Related]
8. Effects of HMA, an analog of amiloride, on the thermosensitivity of tumors in vivo.
Song CW; Lyons JC; Makepeace CM; Griffin RJ; Cragoe EJ
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):133-9. PubMed ID: 8083106
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of hyperthermia effect in vivo by amiloride and DIDS.
Lyons JC; Ross BD; Song CW
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):95-103. PubMed ID: 8416887
[TBL] [Abstract][Full Text] [Related]
10. Effect of timing, dose and interstitial versus nanoparticle delivery of tumor necrosis factor alpha in combinatorial adjuvant cryosurgery treatment of ELT-3 uterine fibroid tumor.
Jiang J; Bischof J
Cryo Letters; 2010; 31(1):50-62. PubMed ID: 20309509
[TBL] [Abstract][Full Text] [Related]
11. A bispecific antibody to enhance radiotherapy by tumor necrosis factor-alpha in human CEA-expressing digestive tumors.
Azria D; Larbouret C; Garambois V; Gourgou S; Martineau P; Robert B; Dubois JB; Pelegrin A
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):580-8. PubMed ID: 14751531
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of antitumor activity of tumor necrosis factor alpha with hyperthermia in a tumor necrosis factor alpha-resistant tumor.
Srinivasan JM; Fajardo LF; Hahn GM
J Natl Cancer Inst; 1990 Dec; 82(24):1904-10. PubMed ID: 2250311
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.
Goel R; Shah N; Visaria R; Paciotti GF; Bischof JC
Nanomedicine (Lond); 2009 Jun; 4(4):401-10. PubMed ID: 19505243
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermic enhancement of the antitumor effect of natural human tumor necrosis factor-alpha and -beta: an in vitro and in vivo study.
Maeda T; Fuchimoto S; Orita K
Jpn J Cancer Res; 1988 Sep; 79(9):1054-61. PubMed ID: 3142836
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Overgaard J; Horsman MR
Int J Hyperthermia; 2001; 17(6):508-19. PubMed ID: 11719967
[TBL] [Abstract][Full Text] [Related]
16. Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor.
Farma JM; Puhlmann M; Soriano PA; Cox D; Paciotti GF; Tamarkin L; Alexander HR
Int J Cancer; 2007 Jun; 120(11):2474-80. PubMed ID: 17330231
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle preconditioning for enhanced thermal therapies in cancer.
Shenoi MM; Shah NB; Griffin RJ; Vercellotti GM; Bischof JC
Nanomedicine (Lond); 2011 Apr; 6(3):545-63. PubMed ID: 21542691
[TBL] [Abstract][Full Text] [Related]
18. Effect of a combination of mild-temperature hyperthermia and nicotinamide on the radiation response of experimental tumors.
Ogawa A; Griffin RJ; Song CW
Radiat Res; 2000 Mar; 153(3):327-31. PubMed ID: 10669555
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antitumor effects following tumor necrosis factor-α gene delivery using nanobubbles and ultrasound.
Horie S; Watanabe Y; Ono M; Mori S; Kodama T
Cancer Sci; 2011 Nov; 102(11):2082-9. PubMed ID: 21824220
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha-based accentuation in cryoinjury--dose, delivery, and response.
Goel R; Swanlund D; Coad J; Paciotti GF; Bischof JC
Mol Cancer Ther; 2007 Jul; 6(7):2039-47. PubMed ID: 17620433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
